Clincosm LogoSign in Get a demo

stage iiia gastric cancer

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IV Gastric Cancer, Stage IIIA Gastric Cancer, Stage IIIB Gastric Cancer Trial (basic nutrition, oral supplement of

Not yet recruiting
  • Stage IV Gastric Cancer
  • +4 more
  • basic nutrition
  • oral supplement of creatine and curcumin
  • (no location specified)
May 16, 2023

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Active, not recruiting
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +12 more
  • copper Cu 64-DOTA-trastuzumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
Has Results
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Stage I Adult Liver Cancer, Stage I Colorectal Cancer, Stage IA Gastric Cancer Trial in Duarte (Computer-Assisted Intervention,

Completed
  • Stage I Adult Liver Cancer
  • +30 more
  • Computer-Assisted Intervention
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +39 more
  • Chicago, Illinois
  • +1 more
May 7, 2020

Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, Gallbladder Carcinoma Trial in United States (Paclitaxel

Completed
  • Adenocarcinoma of Unknown Primary
  • +16 more
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
  • +4 more
  • Chicago, Illinois
  • +7 more
Dec 8, 2017

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Withdrawn
  • Adenocarcinoma of the Esophagus
  • +13 more
  • c-Met inhibitor AMG 337
  • +6 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Oct 17, 2017

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn
  • Estrogen Receptor Negative
  • +22 more
  • Laboratory Biomarker Analysis
  • +2 more
  • (no location specified)
Apr 20, 2017

Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in United States

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +6 more
  • Sacramento, California
  • +29 more
Dec 16, 2015

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +8 more
  • Cleveland, Ohio
    Case Western Reserve University
Apr 15, 2015

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +8 more
  • Duarte, California
  • +4 more
May 9, 2014

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Completed
  • Adenocarcinoma of the Gastroesophageal Junction
  • +8 more
  • irinotecan hydrochloride
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013